Non-executive director
With over 20 years' experience in corporate finance and investment management, Stella's expertise will support the ValiRx board and senior management team to unlock investment potential and accelerate and manage business growth for the company.
In her role, she will also oversee ValiRx's M&A activity, advising on corporate structure and governance, risk management, and shareholders' rights.
Stella was a founding partner of investment management company,
She has held investments in private equity and AIM quoted companies, and non-executive director positions at several companies including The GP Service and GENinCode_Predictive Genetics. She is currently non-executive director at
Of Stella's appointment, Dr
Stella trained at PwC whilst completing her MA in Applied Economics and Statistics at the
'I am really pleased to be joining ValiRx to help enable the company to execute its plans for strong growth,' Stella says. 'Suzy's passion and vision for ValiRx's future is incredibly inspiring, and I am excited to draw on my investment management skills and experience from a range of areas, including biotechnology, manufacturing, and green technology, to help maximise the short- and long-term value of ValiRx's M&A activity, and support relationships with our shareholders.'
ValiRx recently bolstered its drug discovery and therapeutic expertise with the appointment of Dr
Contact:
Tel: +44 (0)2476 796496
Email: info@valirx.com
(C) 2022 Electronic News Publishing, source